PHARMA MAR
ActiveSummary
PHARMA MAR has been active since 2015 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €223,426 and a net result of €8,208. Equity is growing by about 11% per year across the filed financial years. Its solvency ranks better than 46% of 93 sector peers (NACE 21, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
20-03
NBB filing
Annual accounts filed
financial year 2025 · full format
2025
06-06
NBB filing
Annual accounts filed
financial year 2024 · full format
2024
31-12
Financial
Back to profitnet €5,870
Net result €5,870 after one loss-making year.
08-08
Gazette deed
Appointment: KPMG Réviseurs d'Entreprises (commissaire aux comptes)2 facts ▸
Gazette deed
Appointment: KPMG Réviseurs d'Entreprises (commissaire aux comptes)
2 facts ▸
- General meeting, 11-06-2024
- Auditor appointment, KPMG Réviseurs d'Entreprises (commissaire aux comptes)
14-06
NBB filing
Annual accounts filed
financial year 2023 · full format
2023
21-11
Gazette deed
Resignations: Luis MORA CAPITAN (manager) and Elena CALLEJA CRESPO (manager)Appointments: Luis MORA CAPITAN (director) and Elena CALLEJA CRESPO (director) · Legal-form conversion · Capital conversion12 facts ▸
Gazette deed
Resignations: Luis MORA CAPITAN (manager) and Elena CALLEJA CRESPO (manager)
Appointments: Luis MORA CAPITAN (director) and Elena CALLEJA CRESPO (director) · Legal-form conversion · Capital conversion12 facts ▸
- General meeting, 23-10-2023
- Legal-form conversion, “société à responsabilité limitée” (deed in French)
- Capital conversion, “compte de capitaux propres statutairement indisponible” (deed in French)
- Reserve release, “compte de capitaux propres indisponibles, suppression” (deed in French)
- Amendment of the articles (2 times)
- Director resignation, Luis MORA CAPITAN (manager)
- Director resignation, Elena CALLEJA CRESPO (manager)
- Director discharge, Luis MORA CAPITAN
- Director discharge, Elena CALLEJA CRESPO
- Director appointment, Luis MORA CAPITAN (director (not named in the articles))
- Director appointment, Elena CALLEJA CRESPO (director (not named in the articles))
- Registered office clause, “1000 Bruxelles,Rue de la Presse 4” (deed in French)
06-07
NBB filing
Annual accounts filed
financial year 2022 · full format
2022
31-12
Financial
Highest result from 2018 to 2025net €42,068 ▲56%
Operating result €56,122, net result €42,068, both a record.
31-12
Financial
Equity above €200,000equity €210,136 ▲25%
3 profitable years in a row build equity to €210,136.
20-07
NBB filing
Annual accounts filed
financial year 2021 · full format
2021
31-12
Financial
Equity above €150,000equity €168,068 ▲19.1%
2 profitable years in a row build equity to €168,068.
02-08
NBB filing
Annual accounts filed
financial year 2020 · full format · 2 days late
Show earlier events
2020
31-12
Financial
Back to profitnet €33,958
Net result €33,958 after 2 loss-making years.
24-08
NBB filing
Annual accounts filed
financial year 2019 · full format · 24 days late
2019
31-12
Financial
Weakest financial yearnet -€14,611
Net result drops to -€14,611, the lowest in the series; recovery starts the following year.
11-06
NBB filing
Annual accounts filed
financial year 2018 · full format
2018
18-06
NBB filing
Annual accounts filed
financial year 2017 · full format
2017
21-06
NBB filing
Annual accounts filed
financial year 2016 · full format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 11 annual accounts filed, the latest 10 are here; all 11 are under Financials.
2 of 7 deeds read
About the unread acts
Of the 7 Belgian Official Gazette deeds we know for this company, 2 have been read. The other 5 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.